Abstract |
The modulation of the endocannabinoid system is emerging as a viable avenue for the treatment of neurodegeneration, being involved in neuroprotective and anti-inflammatory processes. In particular, indirectly enhancing endocannabinoid signaling to therapeutic levels through FAAH inhibition might be beneficial for neurodegenerative disorders such as Alzheimer's disease, effectively preventing or slowing the progression of the disease. Hence, in the search for a more effective treatment for Alzheimer's disease, in this paper, the multitarget-directed ligand paradigm was applied to the design of carbamates able to simultaneously target the recently proposed endocannabinoid system and the classic cholinesterase system, and achieve effective dual FAAH/ cholinesterase inhibitors. Among the two series of synthesized compounds, while some derivatives proved to be extremely potent on a single target, compounds 9 and 19 were identified as effective dual FAAH/ChE inhibitors, with well-balanced nanomolar activities. Thus, 9 and 19 might be considered as new promising candidates for Alzheimer's disease treatment.
|
Authors | Serena Montanari, Laura Scalvini, Manuela Bartolini, Federica Belluti, Silvia Gobbi, Vincenza Andrisano, Alessia Ligresti, Vincenzo Di Marzo, Silvia Rivara, Marco Mor, Alessandra Bisi, Angela Rampa |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 59
Issue 13
Pg. 6387-406
(07 14 2016)
ISSN: 1520-4804 [Electronic] United States |
PMID | 27309570
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Carbamates
- Enzyme Inhibitors
- Acetylcholinesterase
- Butyrylcholinesterase
- Amidohydrolases
- fatty-acid amide hydrolase
|
Topics |
- Acetylcholinesterase
(metabolism)
- Alzheimer Disease
(drug therapy, metabolism)
- Amidohydrolases
(antagonists & inhibitors, metabolism)
- Butyrylcholinesterase
(metabolism)
- Carbamates
(chemical synthesis, chemistry, pharmacology)
- Cell Line, Tumor
- Dose-Response Relationship, Drug
- Enzyme Inhibitors
(chemical synthesis, chemistry, pharmacology)
- Humans
- Models, Molecular
- Molecular Structure
- Structure-Activity Relationship
|